Hemophilic arthropathy: Considerations in management

Journal of the American Podiatric Medical Association

Volumn 91, Issue 8, 2001, Pages 406-414

  Chang, Thomas J ^a,b   Mohamed, Shenin ^b   Hambleton, Julie ^c  

^a California College of Podiatric Medicine   (United States)

^b San Francisco School of Medicine ^*

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; FEMALE; HEMARTHROSIS; HEMOPHILIA A; HOSPITALIZATION; HUMAN; IMMOBILIZATION; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SURGERY; PROGNOSIS; RADIOGRAPHY; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADULT; FEMALE; HEMARTHROSIS; HEMOPHILIA A; HUMANS; IMMOBILIZATION; MAGNETIC RESONANCE IMAGING; MALE; ORTHOPEDIC PROCEDURES; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0035461126     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/87507315-91-8-406     Document Type: Article

References (64)

1. TEIGLAND JC, TJONNFJORD GE, EVENSEN SA, ET AL: Knee arthroplasty in hemophilia 5-12 year follow-up of 15 patients. Acta Orthop Scand 64: 153, 1993.
2. ARNOLD WD, HILGARTNER MW: Hemophilic arthropathy: current concepts of pathogenesis and management. J Bone Joint Surg Am 59: 287, 1977.
3. HOROSZOWSKI H, HEIM M, SCHULMAN S, ET AL: Multiple joint procedures in a single operative session on hemophilic patients. Clin Orthop 328: 60, 1996.
4. DUTHIE RB, DODD CAF: "Chronic Haemophilic Arthropathy," in The Management of Musculo-skelelal Problems in the Haemophilias, 2nd Ed, ed by RB Duthie, CR Rizza, PLF Giangrande, et al, p 159, Oxford University Press, New York, 1994.
5. HOROSZOWSKI H, HEIM M, SELIGSOHN U, ET AL: "Use of the Laser Scalpel in Orthopaedic Surgery on Haemophilic Patients," in Haemophilia, ed by U Seligsohn, A Rimon, H Horoszowski, p 189, Castle House Publishing Ltd, Turnbridge Wells, UK, 1981.
6. 3. J Arthroplasty 10: 716, 1995.
7. LEVINE PH: "Clinical Manifestations and Therapy of Hemophilias A and B," in Hemostasis and Thrombosis: Basic Principles and Clinical Practice, ed by RW Coleman, J Hirsh, VJ Marder, et al, p 67, JB Lippincott, Philadelphia, 1982.
8. GREENE WB: Synovectomy of the ankle for hemophilic arthropathy. J Bone Joint Surg Am 76: 812, 1994.
9. FABRY G: Early biochemical and histological findings in experimental hemarthrosis in dogs. Arch Orthop Trauma Surg 100: 167, 1982.
10. MAINARDI CL, LEVINE PH, WERB Z, ET AL: Proliferative synovitis in hemophilia: biochemical and morphologic observations. Arthritis Rheum 21: 137, 1978.
11. CANALE ST, DUGDALE M, HOWARD BC: Synovectomy of the knee in young patients with hemophilia. South Med J 81: 1480, 1988.
12. CASSCELLS CD: Commentary: the argument for early arthroscopic synovectomy in patients with severe hemophilia. Arthroscopy 3: 78, 1987.
13. CLARK MW: Knee synovectomy in hemophilia. Orthopedics 1: 285, 1978.
14. DEGNORE LT, WILSON FC: Surgical management of hemophilic arthropathy. Instr Course Lect 38: 383, 1989.
15. WIEDEL JD: Arthroscopic synovectomy of the knee in hemophilia: 10-to-15 year followup. Clin Orthop 328: 46, 1996.
16. BUSSI L, SILVELLO L, BAUDO F, ET AL: Results of synovectomy of the knee in haemophilia. Haematolgica 59: 81, 1974.
17. SHOPNICK RI, BRETTLER DB: Hemostasis: a clinical review of conservative and operative care. Clin Orthop 328: 34, 1996.
18. LOFQVIST T, SANZEN L, PETERSSON C, ET AL: Total hip replacement in patients with hemophilia: 13 hips in 11 patients followed for 1-16 years. Acta Orthop Scand 67: 321, 1996.
19. PEARCE MS, SMITH MA, SAVIDGE GF: Supramalleolar tibial osteotomy for haemophilic arthropathy of the ankle. J Bone and Joint Surg Br 76: 947, 1994.
20. ATKINS RM, HENDERSON NJ, DUTHIE RB: Joint contractures in the hemophilias. Clin Orthop 219: 97, 1987.
21. HOUGHTON GR, DICKSON RA: Lower limb arthrodeses in haemophilia. J Bone Joint Surg Br 60: 387, 1978.
22. LUCK JV JR: Surgical management of advanced hemophilic arthropathy. Prog Clin Biol Res 324: 241, 1990.
23. SMITH MA, URQUHART DR, SAVIDGE GF: The surgical management of varus deformity in haemophilic arthropathy of the knee. J Bone Joint Surg Br 63: 261, 1981.
24. DYSZY-LAUBE B, KAMINSKI W, GIZYCKA I, ET AL: Synovectomy in the treatment of hemophilic arthropathy. J Pediatr Surg 9: 123, 1974.
25. GAMBA G, GRIGNANI G, ASCARI E: Synoviorthesis versus synovectomy in the treatment of recurrent haemophilic haemarthrosis: long-term evaluation. Thromb Haemost 45: 127, 1981.
26. VAN DEN BERG HM, NIEUWENHUIS K, MAUSER-BUNSCHOTEN EP, ET AL: Hemophilia prophylaxis in the Netherlands. Semin Hematol 31: 13, 1994.
27. STEVEN MM, SMALL M, PINKERTON L, ET AL: Non-steroidal anti-inflammatory drugs in haemophilic arthritis: a clinical and laboratory study. Haemostasis 15: 204, 1985.
28. LOFQVIST T, NILSSON IM, PETERSSON C: Orthopaedic surgery in hemophilia: 20 years' experience in Sweden. Clin Orthop 332: 232, 1996.
29. RODRIGUEZ MERCHAN EC, MAGALLON M, GALINDO E: Joint debridement for haemophilic arthropathy of the knee. Int Orthop 18: 135, 1994.
30. AHLBERG A: Treatment and prophylaxis of arthropathy in severe hemophilia. Clin Orthop 53: 135, 1967.
31. BRETTLER DB, LEVINE PH: Factor concentrates for treatment of hemophilia: which one to choose? Blood 73: 2067, 1989.
32. SCHARF R, KUCHARSKI W, NOWAK T: Surgery in hemophilia A patients with factor VIII inhibitor: 10-year experience. World J Surg 20: 1171, 1996.
33. O'MARCAIGH AS, SCHMALZ BJ, SHAUGHNESSY WJ, ET AL: Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor. Mayo Clin Proc 69: 641, 1994.
34. TEIGLAND JC, TJONNFJORD GE, EVENSEN SA, ET AL: Synovectomy for haemophilic arthropathy: 6-21 years of follow-up in 16 patients. J Intern Med 235: 239, 1994.
35. NILSSON IM, BERNTORP E, LJUNG R, ET AL: Prophylactic treatment of severe hemophilia A and B can prevent joint disability. Semin Hematol 31: 5, 1994.
36. ARONSTAM A, BROWNE RS, WASSEF M, ET AL: Clinical features of early haemarthoses in severely affected adolescent haemophiliacs. Clin Lab Haematol 6: 9, 1984.
37. GREENE WB, MCMILLAN CW: Nonsurgical management of hemophilic arthropathy. Instr Course Lect 38: 367, 1989.
38. WILSON FC, MAHEW DE, MCMILLAN CW: Surgical management of musculoskeletal problems in hemophilia. Instr Course Lect 32: 233, 1983.
39. MCMILLAN CW, GREENE WB, BLATT PM, ET AL: The management of musculoskeletal problems in hemophilia. Part I: principles of medical management of hemophilia. Instr Course Lect 32: 210, 1983.
40. UNGER AS, KESSLER CM, LEWIS RJ: Total knee arthroplasty in human imunodeficiency virus-infected hemophiliacs. J Arthroplasty 10: 448, 1995.
41. GOEDERT JJ, KESSLER CM, ALEDORT LM, ET AL: A prospective study of human immunodeficiency virus type I infection and the development of AIDS in subjects with hemophilia. N Engl J Med 321: 1141, 1989.
42. GREENE WB, DEGORE LT, WHITE GC: Orthopaedic procedures and prognosis in hemophilic patients who are seropositive for human immunodeficiency virus. J Bone Joint Surg Am 72: 2, 1990.
43. BRETTLER DB, FORSDERG AD, LEVINE PH, ET AL: The use of porcine factor VIII (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience. Arch Intern Med 149: 1381, 1989.
44. BROWN DC: Adverse events reported in association with the use of monoclonal antibody purified factor VIIIC: monoclate. Semin Hematol 27: 16, 1990.
45. GATTI L, MANNUCCI PM: Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies. Thromb Haemost 51: 379, 1984.
46. GOLDSMITH JC, GORDON EM: Treatment of hemophilia B: serendipitous use of continuous infusion coagulation factor IX. Thromb Res 70: 265, 1993.
47. HEDNER U: Factor VIIa in the treatment of haemophilia. Blood Coagul Fibrinolysis 1: 307, 1990.
48. HEDNER U, FELDSTEDT M, GLAZER S: "Recombinant FVIIa in Hemophilia Treatment," in Hemophilia and von Willebrand's Disease in the 1990s: Proceedings of the XIX Congress of the World Federation of Hemophilia, Washington, DC, August 14-19, 1990, ed by JM Lusher, CM Kessler, p 283, Elsevier Science, New York, 1991.
49. KASPER CK: Treatment of factor VIII inhibitors. Prog Hemost Thromb 9: 57, 1989.
50. KASPER CK: Complications of hemophilia A treatment: factor VIII inhibitors. Ann N Y Acad Sci 614: 97, 1991.
51. LETHAGEN S, EGERVALL K, BERNTORP E, ET AL: The administration of desmopressin by nasal spray: a dose-determination study in patients with mild hemophilia A or von Willebrand's disease. Haemophilia 1: 97, 1995.
52. LUSHER JM, SHAPIRO SS, PALASCAK JE, ET AL: Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. N Engl J Med 303: 421, 1980.
53. MANNUCCI PM: Desmopressin (DDAVP) for treatment of disorders of hemostasis. Prog Hemost Thromb 8: 19, 1986.
54. MANNUCCI PM, BETTAGA D, CATTANEO M: Patterns development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP). Br J Haematol 82: 87, 1992.
55. MARIANI G, SCHEIBEL E, NAGAO T, ET AL: Immunotolerance as treatment of alloantibodies to factor VIII in hemophilia. Emin Hematol (suppl) 31: 62, 1994.
56. NILSSON IM: Factor VIII inhibitor treatment: immune tolerance. Semin Hematol 31 (suppl 4): 44, 1994.
57. NILSSON IM, BERNTORP E, FREIBURGHAUS C: Treatment of patients with factor VIII and IX inhibitors. Thromb Haemost 70: 56, 1993.
58. NILSSON IM, BERNTORP E, ZETTERVALL O: Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII. N Engl J Med 318: 947, 1988.
59. PETRINI P, LINDVALL N, EGBERG N, ET AL: Prophylaxis with factor concentrates in preventing hemophilic arthropathy. Am J Pediatr Hematol Oncol 13: 280, 1991.
60. RAGNI MV, HANLEY EN: Septic arthritis in hemophilic patients and infection with human immunodeficiency virus (HIV). Ann Intern Med 110: 168, 1989.
61. RUDOWSKI WJ, SCHARF R, ZIEMSKI JM: Is major surgery in hemophiliac patients safe? World J Surg 11: 378, 1987.
62. SEREMETIS SV: The clinical use of factor Vila in the treatment of factor VIII inhibitor patients. Semin Haemtol 31 (suppl): 53, 1994.
63. SOREFF J: Joint debridement in the treatment of advanced hemophilic knee arthropathy. Clin Orthop 191: 179, 1984.
64. WEBER DJ, BECHERER PR, RUTALA WA, ET AL: Nosocomial infection rate as a function of human immunodeficiency virus type I status in hemophiliacs. Am J Med (suppl) 91: 206, 1991.